Global Surgical Suture Market Size Opportunities by Region, Competitive Analysis by Key Players and Growth Forecast

Surgical Suture Market was valued at USD 4.99 Bn. in 2025 and the total Surgical Suture revenue is expected to grow at 6.1% from 2026 to 2032, reaching nearly USD 7.11 Bn.

Surgical Suture Market Overview:

A surgical suture, often known as a stitch, is a medical device used to keep body tissues together after an injury or surgery and to approximate wound margins. In most cases, a needle with a length of thread connected is used for application. A suture is classified into several varieties based on needle form and size, as well as thread material and properties. Sutures with amazing mechanical and physical qualities have been produced as a consequence of several adaptations and technical developments in material science. They not only accomplish their basic role of wound closure, but they also provide antibacterial characteristics and, more recently, the elimination of the surgical knot with barbed sutures and the replacement of skin sutures with adhesives. A surgeon must create their own particular choice of the suture so that familiarity translates to consistent reproducible results.

The surgical suture market has grown steadily, owing mostly to the rising number of surgical operations conducted globally. The advantageous reimbursement status for a variety of surgical procedures, as well as the introduction of improved sutures, are driving the growth of this market. However, the availability of alternative wound care management solutions, as well as the rising demand for minimally invasive operations, are expected to impede the market's growth to some extent.To know about the Research Methodology:-Request Free Sample Report

Report Scope:

The Surgical Suture market is segmented based on Type, Filament, Application, End-User, and Region. The growth of various segments helps report users in acquiring knowledge of the many growth factors expected to be prevalent throughout the market and develop different strategies to help identify core application areas and the gap in the target market. The report provides an in-depth analysis of the market and contains meaningful insights, facts, historical data, and statistically supported and industry-validated market statistics. It also includes estimates based on an appropriate set of assumptions and methodologies.

A bottom-up approach has been used to estimate the market size. Key Players in the Surgical Suture market are identified through secondary research and their market revenues are determined through primary and secondary research. Secondary research included a review of annual and financial reports of leading manufacturers, while primary research included interviews with important opinion leaders and industry experts such as skilled front-line personnel, entrepreneurs, and marketing professionals. Some of the leading key players in the global Surgical Suture market include Medtronic, Johnson & Johnson, and Advanced Medical Solutions Group. They are continuously strategizing on mergers and acquisitions, strategic alliances, joint ventures, and partnerships for the growth of their market shares.

Surgical Suture Market Dynamics:

Technological Advances Hastening the Adoption of Surgical Sutures:

Some of the most significant technical developments in the global surgical suture market have occurred in the recent few years. Such industrial activity has resulted in increased product uptake and demand for surgical sutures. Compared to other wound closure devices on the market, the use of surgical sutures has risen pretty significantly. Some of the technological advances incorporated in these sutures include the use of various synthetic materials with remarkable tissue-retaining capabilities and almost little danger of infection or scar formation. Additionally, continuous research is being conducted to enhance suture coatings, braiding technologies, and antimicrobial coatings. Only one product, Triclosan-coated polyglactin 910 or Vicryl Plus Antibacterial produced by Ethicon has been shown to lower surgical site infection rate by 30%. Additionally, these sutures' handling and tension forces were determined to be equivalent to typical surgical suture products.

An increasing number of surgical operations to boost Surgical Suture Market

The aging population is more prone to chronic illnesses and disorders, necessitating numerous procedures. Adults aged 65 and over make up a sizable proportion of procedures done in the United States. The increased aging of the population, as well as the increasing prevalence of numerous chronic conditions, are expected to considerably increase the number of operations done. Also, non-communicable diseases are expected to account for more than half of the illness burden in low-income nations and more than three-quarters of the disease burden in middle-income countries by 2030. NCDs account for more than 85% of the burden in the senior population in poor, medium, and high-income nations. The increased incidence of chronic illnesses, particularly among the senior population, would significantly increase the number of surgical treatment operations performed, driving demand surgical suture market.

Availability of alternative wound care treatment products:

Alternatives to surgical sutures include topical skin adhesives, hemostatic and sealing agents (such as fibrin sealants, surgical sealants, gelatin-based sealants, and thrombin fleeces), and wound closure devices (such as stapling devices and wound closure strips).

These alternative goods have several advantages. Stapling, for example, is faster than suturing. Also, the area required suturing is an essential issue in material selection. In the event of head traumas, a stapler can function rapidly, reducing time and blood loss, making it a better option than sutures. Similarly, tiny cuts and wounds (less than 10 cm) can be closed using tissue adhesives in a reasonably painless technique for young patients, eliminating the need for suture removal. Smaller lacerations can also be closed with wound closure strips and tapes. In the case of older patients, especially those with frail skin, these products give improved closure and prognosis. The availability of alternatives is a major barrier for the surgical suture market due to their efficiency and benefits over surgical sutures.

Surgical Suture Market Segment Analysis:

By Type, the absorbable segment held the largest revenue share of over 56% in 2025 because of its capacity to offer temporary support to wounds while they heal and its ability to tolerate regular stress. Also, the need for absorbable sutures is always increasing, which might be related to their inherent degradability. As a result, leading market players are spending on R&D efforts, which is expected to assist the absorbable sector to grow in the future. Due to their inability to deteriorate or disintegrate, non-absorbable sutures have a lower market share than absorbable sutures. These sutures are primarily used in harsh interior environments when absorbable sutures are unable to provide acceptable criteria. These sutures are mostly utilized in slow-healing tissues or for long-term closures.

By Application, the other segment dominated the market for surgical sutures and held a revenue share of over 41% in 2023. In 2023, the cardiovascular surgery segment had the second-largest revenue share. This is due to the high prevalence of cardiac disorders, the availability of adequate expertise in the field, favorable reimbursement conditions, and advancements in diagnostics. This is causing a large increase in the number of cardiac procedures, which is increasing the demand for surgical sutures throughout the forecast period. Orthopedic surgery emerged as the third-largest application sector in 2023 and is expected to grow rapidly during the forecast period. This is due to an increase in the number of traffic accidents, which is leading to an increase in the number of orthopedic injuries. According to the United States Department of Transportation, an estimated 20,160 persons died in car accidents in the first half of 2023.

Surgical Suture Market Regional Insights:

North America held the dominant share in 2025, accounting for approximately 44% of the global surgical suture market. United States remained the largest contributor due to high surgical volumes, advanced healthcare infrastructure, and broad use of premium wound-closure technologies. Growth is supported by orthopedic, cardiovascular, and general surgery procedures, alongside high healthcare spending and favorable reimbursement systems.

Europe represented the second-largest market, supported by strong healthcare systems in Germany, United Kingdom, and France. Demand is increasing through minimally invasive surgeries, elderly patient populations, and rising preference for synthetic absorbable sutures. Government healthcare investments continue to support procurement across hospitals and ambulatory centers.Asia Pacific is the fastest-growing region, driven by expanding healthcare infrastructure in China, India, and Japan. Rising medical tourism, increasing surgeries, and local manufacturing of cost-effective sutures are strengthening regional growth. Aging populations and improved access to surgical care continue to expand the market across emerging economies.South  America and Middle East and Africa are emerging markets, supported by improving hospital infrastructure, rising trauma cases, and broader access to surgical care, particularly in Brazil, Mexico, Saudi Arabia, and South Africa.

Surgical Suture Market Recent Development

• In 2025, Johnson & Johnson subsidiary Ethicon maintained its leading position in the global surgical suture market through expanded adoption of antimicrobial and barbed suture portfolios for minimally invasive and specialty procedures.
• In 2025, Medtronic strengthened its surgical closure segment by integrating advanced absorbable sutures with its broader surgical technologies platform, targeting laparoscopic and robotic-assisted procedures.
• In late 2025, B. Braun expanded its biodegradable suture portfolio across Europe and Asia, focusing on improved tissue compatibility and faster healing applications in cardiovascular and general surgeries.
• In 2025, Smith+Nephew increased investment in advanced wound management and precision closure technologies, supporting its surgical sutures portfolio in orthopedic and trauma procedures.
• In 2025, Advanced Medical Solutions accelerated expansion in tissue repair and surgical sealant technologies, enhancing its competitive position in absorbable suture materials.
• In 2025, Corza Medical expanded global distribution of specialty sutures through strategic hospital partnerships, strengthening its presence in North America and Asia Pacific.
• In 2025, Healthium Medtech continued expanding its surgical sutures manufacturing capacity in India, supporting domestic demand and export opportunities across emerging healthcare markets.

Surgical Suture Market Scope: Inquire before buying

Surgical Suture Market, by Region

North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina Rest of South America)

Leading Manufacturers in the Surgical Suture Market are:

1. Medtronic plc (US)
2. Johnson & Johnson (US)
3. Sutumed (US)
4. Vital Sutures (US)
5. Unilene (US)
6. Riverpoint Medical (US)
7. CONMED Corporation (US)
8. Boston Scientific Corporation (US)
9. DemeTECH Corporation (US)
10. Stryker Corporation (US)
11. Zimmer Biomet (US)
12. Advanced Medical Solutions Group plc (UK)
13. Smith & Nephew (UK)
14. B. Braun Melsungen (Germany)
15. Peters Surgical (France)
16. Genia SA (France)
17. Mellon Medical (Netherlands)
18. Biosintex (Romania)
19. Dolphin Sutures (India)
20. Healthium MedTech (India)
21. GPC Medical (India)
22. Lotus Surgicals (India)
23. CPT Sutures (Vietnam)
24. ARC Medical Supplies(Beijing) Co., Ltd. (China)
25. Tagumedica SA (Peru)